Global Nanopharmaceuticals Industry Report 2015

Published: December 2015
No. of Pages: 172
   

This is a professional and in-depth study on the current state of the Nanopharmaceuticals industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Nanopharmaceuticals market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Nanopharmaceuticals industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 263 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Global Nanopharmaceuticals Industry Report 2015

Table of Contents

1 Industry Overview 1
1.1 Definition and Specifications of Nanopharmaceuticals 1
1.1.1 Definition of Nanopharmaceuticals 1
1.2 Classification of Nanopharmaceuticals 2
1.2.1 Liposomes 3
1.2.2 Polymeric Micelles 4
1.2.3 Solid Lipid Nanoparticles 4
1.2.4 Microemulsion and Nnanoemulsion 5
1.2.5 Nanosuspension 5
1.3 Applications of Nanopharmaceuticals 5
1.3.1 Cancer and Tumor 6
1.3.2 Autoimmune Disorders 7
1.3.3 Inflammation 8
1.3.4 Others 8
1.4 Industry Chain Structure of Nanopharmaceuticals 9
1.5 Industry Overview and Major Regions Status of Nanopharmaceuticals 9
1.6 Industry Policy Analysis of Nanopharmaceuticals 9
1.7 Industry News Analysis of Nanopharmaceuticals 10

2 Manufacturing Cost Structure Analysis of Nanopharmaceuticals 13
2.1 Raw Material Analysis of Nanopharmaceuticals 13
2.2 Technology Theory Analysis of Nanopharmaceuticals 14
2.3 Equipment Suppliers and Price Analysis of Nanopharmaceuticals 15
2.4 Labor Cost Analysis of Nanopharmaceuticals 17
2.5 Other Costs Analysis of Nanopharmaceuticals 19
2.6 Manufacturing Cost Structure Analysis of Nanopharmaceuticals 20

3 Analysis of Nanopharmaceuticals Technology and Market Opportunity 22
3.1 Nanopharmaceuticals Technology 22
3.1.1 Nanoemulsion 22
3.1.2 Liposomes 24
3.1.3 Nanosuspension 26
3.2 Nanopharmaceuticals Market Opportunity 28
3.2.1 Tumors and Cancers 28
3.2.2 Autoimmune Diseases 32
3.2.3 Inflammation 35

4 Technical Data and Manufacturing Plants Analysis of Nanopharmaceuticals 37
4.1 Revenue and Commercial Production Date of Global Key Manufacturers in 2014 37
4.2 Manufacturing Plants Distribution of Global Key Nanopharmaceuticals Manufacturers in 2014 38
4.3 R&D Status and Technology Source of Global Nanopharmaceuticals Key Manufacturers in 2014 39

5 Revenue Analysis of Nanopharmaceuticals by Regions, and Applications 41
5.1 Global Revenue of Nanopharmaceuticals by Regions 2010-2015 41
5.2 Production Revenue Analysis of Global Nanopharmaceuticals Key Manufacturers in 2015 45
5.3 USA Revenue, Gross and Gross Margin of Nanopharmaceuticals 2010-2015 46
5.4 Europe Revenue, Gross and Gross Margin of Nanopharmaceuticals 2010-2015 46
5.5 Japan Revenue, Gross and Gross Margin of Nanopharmaceuticals 2010-2015 46
5.6 China Revenue, Gross and Gross Margin of Nanopharmaceuticals 2010-2015 47
5.7 USA Supply, Import, Export and Consumption Revenue of Nanopharmaceuticals 2010-2015 47
5.8 Europe Supply, Import, Export and Consumption Revenue of Nanopharmaceuticals 2010-2015 47
5.9 Japan Supply, Import, Export and Consumption Revenue of Nanopharmaceuticals 2010-2015 48
5.10 China Supply, Import, Export and Consumption Revenue of Nanopharmaceuticals 2010-2015 48

6 Global and Global Nanopharmaceuticals Market by Type and Application 49
6.1 Global Market Nanopharmaceuticals Market by Type 49
6.1.1 Revenue of Global Nanopharmaceuticals Market by Type 49
6.1.2 Global Nanopharmaceuticals Market Share by Type 50
6.2 Global Nanopharmaceuticals Market by Application 53
6.2.1 Revenue of Global Nanopharmaceuticals Market by Application 53
6.2.2 Global Nanopharmaceuticals Market Share by Application 54

7 Analysis of Nanopharmaceuticals Revenue, Supply, Sales and Market Status 2010-2015 58
7.1 Capacity and Revenue of Nanopharmaceuticals 2010-2015 58
7.2 Revenue Market Share Analysis of Nanopharmaceuticals 2010-2015 63
7.3 Consumption Revenue Overview of Nanopharmaceuticals 2010-2015 69
7.4 Supply, Sales and Gap of Nanopharmaceuticals 2010-2015 73
7.5 Gross Margin of Nanopharmaceuticals 2010-2015 74

8 Key Manufacturers Analysis of Nanopharmaceuticals Industry 77
8.1 Merck 77
8.1.1 Merck Company Profile 77
8.1.2 Technology and R&D Status 78
8.1.3 Gross and Revenue 78
8.1.4 Contact Information 79
8.2 Pfizer 80
8.2.1 Pfizer Company Profile 80
8.2.2 Technology and R&D Status 80
8.2.3 Gross and Revenue 81
8.2.4 Contact Information 82
8.3 Novartis 82
8.3.1 Novartis Company Profile 82
8.3.2 Technology and R&D Status 83
8.3.3 Gross and Revenue 84
8.3.4 Contact Information 85
8.4 Abbott 85
8.4.1 Abbott Company Profile 85
8.4.2 Technology and R&D Status 86
8.4.3 Gross and Revenue 86
8.4.4 Contact Information 87
8.5 GlaxoSmithKline 88
8.5.1 GlaxoSmithKline Company Profile 88
8.5.2 Technology and R&D Status 88
8.5.3 Gross and Revenue 89
8.5.4 Contact Information 90
8.6 Roche 90
8.6.1 Roche Company Profile 90
8.6.2 Technology and R&D Status 91
8.6.3 Gross and Revenue 91
8.6.4 Contact Information 92
8.7 Sanofi 93
8.7.1 Sanofi Company Profile 93
8.7.2 Technology and R&D Status 94
8.7.3 Gross and Revenue 94
8.7.4 Contact Information 95
8.8 Eli Lilly 95
8.8.1 Eli Lilly Company Profile 95
8.8.2 Technology and R&D Status 96
8.8.3 Gross and Revenue 96
8.8.4 Contact Information 97
8.9 Astrazeneca 98
8.9.1 Astrazeneca Company Profile 98
8.9.2 Technology and R&D Status 99
8.9.3 Gross and Revenue 99
8.9.4 Contact Information 100
8.10 Johnson & Johnson 101
8.10.1 Johnson & Johnson Company Profile 101
8.10.2 Technology and R&D Status 102
8.10.3 Gross and Revenue 102
8.10.4 Contact Information 103
8.11 Celgene 103
8.11.1 Celgene Company Profile 103
8.11.2 Technology and R&D Status 105
8.11.3 Gross and Revenue 105
8.11.4 Contact Information 106
8.12 Novavax 107
8.12.1 Novavax Company Profile 107
8.12.2 Technology and R&D Status 108
8.12.3 Gross and Revenue 108
8.12.4 Contact Information 109
8.13 Stryker 110
8.13.1 Stryker Company Profile 110
8.13.2 Technology and R&D Status 110
8.13.3 Gross and Revenue 111
8.13.4 Contact Information 112
8.14 Gilead Sciences 112
8.14.1 Gilead Sciences Company Profile 112
8.14.2 Technology and R&D Status 113
8.14.3 Gross and Revenue 113
8.14.4 Contact Information 115
8.15 OSI Pharmaceuticals 115
8.15.1 OSI Pharmaceuticals Company Profile 115
8.15.2 Technology and R&D Status 116
8.15.3 Gross and Revenue 116
8.15.4 Contact Information 117
8.16 Kadmon Pharmaceuticals 117
8.16.1 Kadmon Pharmaceuticals Company Profile 117
8.16.2 Technology and R&D Status 118
8.16.3 Gross and Revenue 119
8.16.4 Contact Information 120
8.17 Samyang Biopharm 120
8.17.1 Samyang Biopharm Company Profile 120
8.17.2 Technology and R&D Status 121
8.17.3 Gross and Revenue 122
8.17.4 Contact Information 123
8.18 Mitsubishi Pharma 123
8.18.1 Mitsubishi Pharma Company Profile 123
8.18.2 Technology and R&D Status 124
8.18.3 Gross and Revenue 124
8.18.4 Contact Information 126
8.19 Kaken Pharmaceutical 126
8.19.1 Kaken Pharmaceutical Company Profile 126
8.19.2 Technology and R&D Status 127
8.19.3 Gross and Revenue 127
8.19.4 Contact Information 128
8.20 Selecta Biosciences 128
8.20.1 Selecta Biosciences Company Profile 128
8.20.2 Technology and R&D Status 129
8.20.3 Gross and Revenue 130
8.20.4 Contact Information 131
8.21 Par Pharmaceutical 131
8.21.1 Par Pharmaceutical Company Profile 131
8.21.2 Technology and R&D Status 132
8.21.3 Gross and Revenue 133
8.21.4 Contact Information 134
8.22 Cerulean Pharma 134
8.22.1 Cerulean Pharma Company Profile 134
8.22.2 Technology and R&D Status 135
8.22.3 Gross and Revenue 136
8.22.4 Contact Information 137
8.23 Navidea Biopharmaceuticals 138
8.23.1 Navidea Biopharmaceuticals Company Profile 138
8.23.2 Technology and R&D Status 138
8.23.3 Gross and Revenue 139
8.23.4 Contact Information 140
8.24 Lummy 141
8.24.1 Lummy Company Profile 141
8.24.2 Technology and R&D Status 141
8.24.3 Gross and Revenue 142
8.24.4 Contact Information 143

9 Marketing Trader or Distributor Analysis of Nanopharmaceuticals 144
9.1 Marketing Channels Status of Nanopharmaceuticals 144
9.2 Traders or Distributors of Nanopharmaceuticals with Contact Information 145
9.3 Global Nanopharmaceuticals Industry Gross Margin by Region Forecast 146

10 Development Trend of Nanopharmaceuticals Industry 2016-2021 147
10.1 Capacity and Revenue Overview of Nanopharmaceuticals 2016-2021 147
10.2 Revenue Market Share Analysis of Nanopharmaceuticals by Type 2016-2021 148
10.3 Revenue Market Share Analysis of Nanopharmaceuticals by Application 2016-2021 148
10.4 Import, Export and Consumption of Nanopharmaceuticals 2016-2021 149
10.5 2016-2021 Nanopharmaceuticals Revenue 150

11 Industry Chain Suppliers with Contact Information of Nanopharmaceuticals 151
11.1 Manufacturing Equipment Suppliers of Nanopharmaceuticals with Contact Information 151
11.2 Major Suppliers of Nanopharmaceuticals with Contact Information 152
11.3 Key Consumers of Nanopharmaceuticals with Contact Information 153

12 Conclusion of the Global Nanopharmaceuticals Industry Report 2015 154

List of Tables and Figures

Figure Picture of Nanopharmaceuticals 1
Figure Advantage of Nanopharmaceuticals 2
Table Classification of Nanopharmaceuticals 2
Figure Global Production Market Share of Nanopharmaceuticals by Type in 2014 3
Figure Liposomes Picture 3
Figure Polymeric Micelles Picture 4
Figure Solid Lipid Nanoparticles Picture 4
Figure Microemulsion and Nnanoemulsion 5
Table Application Fields of Nanopharmaceuticals Products 5
Figure 2014 Global Nanopharmaceuticals Major Applications Sales Share 6
Figure Cancer and Tumor Examples 7
Figure Autoimmune Disorders Examples 7
Figure Inflammation Examples 8
Figure Industry Chain Structure of Nanopharmaceuticals 9
Table Industry Policy of Nanopharmaceuticals 9
Table Industry News List of Nanopharmaceuticals 10
Table Major Raw Materials of Nanopharmaceuticals already on the Market 13
Figure Basis of Nanopharmaceuticals Biological Effects 15
Table Global Major Suppliers of Nanopharmaceuticals Equipment 15
Figure 2014 APAC Overview of Average Monthly Labor Cost 17
Figure 2014 Americas Overview of Average Monthly Labor Cost 17
Figure 2014 EMEA Overview of Average Monthly Labor Cost 18
Figure 2010-2015 USA Employment Cost Index (ECI) 18
Figure 2010-2014 China Average Wage of Worker and Growth Rate 19
Table 2014 Global Electricity Price of Industry (USD/KW•h) by Country 19
Figure Manufacturing Cost Structure Analysis of Nanopharmaceuticals in 2014 21
Figure Picture of Nanoemulsion 23
Table Physical Characteristics of Emulsion Droplets and Microscale Emulsions (Normal Type) 24
Table Advantages and Disadvantages of Liposome 25
Table Benefits of Drug Load in Liposomes 25
Figure Introduction of Nanosuspension 28
Figure Typical Cancer Treatment Schematic 30
Figure All Cancers Combined Incidence Rates by State 31
Figure All Cancers Combined Death Rates by State 31
Table Prevalence of RA by Gender in Various Countries in 2014 34
Table Incidence and Prevalence of Rheumatoid Arthritis in Various Populations in 2014 34
Figure Typical Arthritis 36
Table Revenue (Million USD) and Found Date of Global Nanopharmaceuticals Key Manufacturers in 2015 37
Table Manufacturing Plants Distribution of Global Key Nanopharmaceuticals Manufacturers in 2014 38
Table R&D Status and Technology Source of Global Nanopharmaceuticals Key Manufacturers in 2014 39
Table Global Production Revenue of Nanopharmaceuticals by Regions 2010-2015 (Million USD) 41
Figure Global Production Revenue Market Share of Nanopharmaceuticals by Regions in 2010 42
Figure Global Production Revenue Market Share of Nanopharmaceuticals by Regions in 2011 42
Figure Global Production Revenue Market Share of Nanopharmaceuticals by Regions in 2012 43
Figure Global Production Revenue Market Share of Nanopharmaceuticals by Regions in 2013 43
Figure Global Production Revenue Market Share of Nanopharmaceuticals by Regions in 2014 44
Figure Global Production Revenue Market Share of Nanopharmaceuticals by Regions in 2015 44
Figure Production Revenue Comparison of Global Nanopharmaceuticals Key Manufacturers in 2015 (Million USD) 45
Table USA Revenue (Million USD), Gross (Million USD) and Gross Margin of Nanopharmaceuticals 2010-2015 46
Table Europe Revenue (Million USD), Gross (Million USD) and Gross Margin of Nanopharmaceuticals 2010-2015 46
Table Japan Revenue (Million USD), Gross (Million USD) and Gross Margin of Nanopharmaceuticals 2010-2015 46
Table China Revenue (Million USD), Gross (Million USD) and Gross Margin of Nanopharmaceuticals 2010-2015 47
Table USA Supply, Import, Export and Consumption Revenue of Nanopharmaceuticals 2010-2015 (Million USD) 47
Table Europe Supply, Import, Export and Consumption Revenue of Nanopharmaceuticals 2010-2015 (Million USD) 47
Table Japan Supply, Import, Export and Consumption Revenue of Nanopharmaceuticals 2010-2015 (Million USD) 48
Table China Supply, Import, Export and Consumption Revenue of Nanopharmaceuticals 2010-2015 (Million USD) 48
Table Revenue (Million USD) of Global Nanopharmaceuticals Market by Type, 2010-2015 49
Table Revenue Share of Global Nanopharmaceuticals Market by Type, 2010-2015 49
Figure Revenue Share of Global Nanopharmaceuticals Market by Type, 2010 50
Figure Revenue Share of Global Nanopharmaceuticals Market by Type, 2011 50
Figure Revenue Share of Global Nanopharmaceuticals Market by Type, 2012 51
Figure Revenue Share of Global Nanopharmaceuticals Market by Type, 2013 51
Figure Revenue Share of Global Nanopharmaceuticals Market by Type, 2014 52
Figure Revenue Share of Global Nanopharmaceuticals Market by Type, 2015 52
Table Revenue (Million USD) of Global Nanopharmaceuticals Market by Application, 2010-2015 53
Table Revenue Share of Global Nanopharmaceuticals Market by Application, 2010-2015 53
Figure Revenue Share of Global Nanopharmaceuticals Market by Application, 2010 54
Figure Revenue Share of Global Nanopharmaceuticals Market by Application, 2011 55
Figure Revenue Share of Global Nanopharmaceuticals Market by Application, 2012 55
Figure Revenue Share of Global Nanopharmaceuticals Market by Application, 2013 56
Figure Revenue Share of Global Nanopharmaceuticals Market by Application, 2014 56
Figure Revenue Share of Global Nanopharmaceuticals Market by Application, 2015 57
Table Global and Major Manufacturers Revenue Nanopharmaceuticals 2010-2015 (Million USD) 58
Table 2010-2015 Global Revenue Market Share of Major Nanopharmaceuticals Manufacturers 2010-2015 59
Figure Global Revenue (Million USD) and Growth Rate of Nanopharmaceuticals 2010-2015 60
Figure USA Revenue (Million USD) and Growth Rate of Nanopharmaceuticals 2010-2015 60
Figure Europe Revenue (Million USD) and Growth Rate of Nanopharmaceuticals 2010-2015 61
Figure Japan Revenue (Million USD) and Growth Rate of Nanopharmaceuticals 2010-2015 61
Figure China Revenue (Million USD) and Growth Rate of Nanopharmaceuticals 2010-2015 62
Figure Global Revenue Market Share of Major Nanopharmaceuticals Manufacturers in 2010 63
Figure Global Revenue Market Share of Major Nanopharmaceuticals Manufacturers in 2011 64
Figure Global Revenue Market Share of Major Nanopharmaceuticals Manufacturers in 2012 65
Figure Global Revenue Market Share of Major Nanopharmaceuticals Manufacturers in 2013 66
Figure Global Revenue Market Share of Major Nanopharmaceuticals Manufacturers in 2014 67
Figure Global Revenue Market Share of Major Nanopharmaceuticals Manufacturers in 2015 68
Figure Global Consumption Revenue (Million USD) and Growth Rate of Nanopharmaceuticals 2010-2015 69
Table Global Consumption Revenue of Nanopharmaceuticals by Regions 2010-2015 (Million USD) 69
Figure Global Consumption Value of Nanopharmaceuticals by Regions in 2010 70
Figure Global Consumption Value of Nanopharmaceuticals by Regions in 2015 70
Figure USA Consumption Revenue (Million USD) and Growth Rate of Nanopharmaceuticals 2010-2015 71
Figure Europe Consumption Revenue (Million USD) and Growth Rate of Nanopharmaceuticals 2010-2015 71
Figure Japan Consumption Revenue (Million USD) and Growth Rate of Nanopharmaceuticals 2010-2015 72
Figure China Consumption Revenue (Million USD) and Growth Rate of Nanopharmaceuticals 2010-2015 72
Table Global Production Revenue, Sales Revenue and Gap of Nanopharmaceuticals 2010-2015 (Million USD) 73
Table USA Production Revenue, Sales Revenue and Gap of Nanopharmaceuticals 2010-2015 (Million USD) 73
Table Europe Production Revenue, Sales Revenue and Gap of Nanopharmaceuticals 2010-2015 (Million USD) 73
Table Japan Production Revenue, Sales Revenue and Gap of Nanopharmaceuticals 2010-2015 (Million USD) 73
Table China Supply, Sales and Gap of Nanopharmaceuticals 2010-2015 (Million USD) 73
Table Cost of Global Nanopharmaceuticals Major Manufacturers 2010-2015 (M USD) 74
Table Gross of Global Nanopharmaceuticals Major Manufacturers 2010-2015 (M USD) 75
Table Gross Margin of Global Nanopharmaceuticals Major Manufacturers 2010-2015 75
Table Merck Company Profile 77
Table Technology Profile of Merck 78
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Merck 2010-2015 78
Figure Nanopharmaceuticals Revenue Growth Rate 79
Figure Nanopharmaceuticals Revenue Market Share of Merck 2010-2015 79
Table Contact Information of Merck 79
Table Pfizer Company Profile 80
Table Technology Profile of Pfizer 80
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Pfizer 2010-2015 81
Figure Nanopharmaceuticals Revenue Growth Rate 81
Figure Nanopharmaceuticals Revenue Market Share of Pfizer 2010-2015 82
Table Contact Information of Pfizer 82
Table Novartis Company Profile 82
Table Technology Profile of Novartis 83
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Novartis 2010-2015 84
Figure Nanopharmaceuticals Revenue Growth Rate 84
Figure Nanopharmaceuticals Revenue Market Share of Novartis 2010-2015 85
Table Contact Information of Novartis 85
Table Abbott Company Profile 85
Table Technology Profile of Abbott 86
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Abbott 2010-2015 86
Figure Nanopharmaceuticals Revenue Growth Rate 87
Figure Nanopharmaceuticals Revenue Market Share of Abbott 2010-2015 87
Table Contact Information of Abbott 87
Table GlaxoSmithKline Company Profile 88
Table Technology Profile of GlaxoSmithKline 88
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of GlaxoSmithKline 2010-2015 89
Figure Nanopharmaceuticals Revenue Growth Rate 89
Figure Nanopharmaceuticals Revenue Market Share of GlaxoSmithKline 2010-2015 90
Table Contact Information of GlaxoSmithKline 90
Table Roche Company Profile 90
Table Technology Profile of Roche 91
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Roche 2010-2015 91
Figure Nanopharmaceuticals Revenue Growth Rate 92
Figure Nanopharmaceuticals Revenue Market Share of Roche 2010-2015 92
Table Contact Information of Roche 92
Table Sanofi Company Profile 93
Table Technology Profile of Sanofi 94
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Sanofi 2010-2015 94
Figure Nanopharmaceuticals Revenue Growth Rate 94
Figure Nanopharmaceuticals Revenue Market Share of Sanofi 2010-2015 95
Table Contact Information of Sanofi 95
Table Eli Lilly Company Profile 95
Table Technology Profile of Eli Lilly 96
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Eli Lilly 2010-2015 96
Figure Nanopharmaceuticals Revenue Growth Rate 97
Figure Nanopharmaceuticals Revenue Market Share of Eli Lilly 2010-2015 97
Table Contact Information of Eli Lilly 97
Table Astrazeneca Company Profile 98
Table Technology Profile of Astrazeneca 99
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Astrazeneca 2010-2015 99
Figure Nanopharmaceuticals Revenue Growth Rate 100
Figure Nanopharmaceuticals Revenue Market Share of Astrazeneca 2010-2015 100
Table Contact Information of Astrazeneca 100
Table Johnson & Johnson Company Profile 101
Table Technology Profile of Johnson & Johnson 102
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Johnson & Johnson 2010-2015 102
Figure Nanopharmaceuticals Revenue Growth Rate 102
Figure Nanopharmaceuticals Revenue Market Share of Johnson & Johnson 2010-2015 103
Table Contact Information of Johnson & Johnson 103
Table Celgene Company Profile 103
Table Technology Profile of Celgene 105
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Celgene 2010-2015 105
Figure Nanopharmaceuticals Revenue Growth Rate 106
Figure Nanopharmaceuticals Revenue Market Share of Celgene 2010-2015 106
Table Contact Information of Celgene 106
Table Novavax Company Profile 107
Table Technology Profile of Novavax 108
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Novavax 2010-2015 108
Figure Nanopharmaceuticals Revenue Growth Rate 109
Figure Nanopharmaceuticals Revenue Market Share of Novavax 2010-2015 109
Table Contact Information of Novavax 109
Table Stryker Company Profile 110
Table Technology Profile of Stryker 110
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Stryker 2010-2015 111
Figure Nanopharmaceuticals Revenue Growth Rate 111
Figure Nanopharmaceuticals Revenue Market Share of Stryker 2010-2015 112
Table Contact Information of Stryker 112
Table Gilead Sciences Company Profile 112
Table Technology Profile of Gilead Sciences 113
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Gilead Sciences 2010-2015 113
Figure Nanopharmaceuticals Revenue Growth Rate 114
Figure Nanopharmaceuticals Revenue Market Share of Gilead Sciences 2010-2015 114
Table Contact Information of Gilead Sciences 115
Table OSI Pharmaceuticals Company Profile 115
Table Technology Profile of OSI Pharmaceuticals 116
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of OSI Pharmaceuticals 2010-2015 116
Figure Nanopharmaceuticals Revenue Growth Rate 116
Figure Nanopharmaceuticals Revenue Market Share of OSI Pharmaceuticals 2010-2015 117
Table Contact Information of OSI Pharmaceuticals 117
Table Kadmon Pharmaceuticals Company Profile 117
Table Technology Profile of Kadmon Pharmaceuticals 118
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Kadmon Pharmaceuticals 2010-2015 119
Figure Nanopharmaceuticals Revenue Growth Rate 119
Figure Nanopharmaceuticals Revenue Market Share of Kadmon Pharmaceuticals 2010-2015 120
Table Contact Information of Kadmon Pharmaceuticals 120
Table Samyang Biopharm Company Profile 120
Table Technology Profile of Samyang Biopharm 121
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Samyang Biopharm 2010-2015 122
Figure Nanopharmaceuticals Revenue Growth Rate 122
Figure Nanopharmaceuticals Revenue Market Share of Samyang Biopharm 2010-2015 123
Table Contact Information of Samyang Biopharm 123
Table Mitsubishi Pharma Company Profile 123
Table Technology Profile of Mitsubishi Pharma 124
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Mitsubishi Pharma 2010-2015 124
Figure Nanopharmaceuticals Revenue Growth Rate 125
Figure Nanopharmaceuticals Revenue Market Share of Mitsubishi Pharma 2010-2015 125
Table Contact Information of Mitsubishi Pharma 126
Table Kaken Pharmaceutical Company Profile 126
Table Technology Profile of Kaken Pharmaceutical 127
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Kaken Pharmaceutical 2010-2015 127
Figure Nanopharmaceuticals Revenue Growth Rate 127
Figure Nanopharmaceuticals Revenue Market Share of Kaken Pharmaceutical 2010-2015 128
Table Contact Information of Kaken Pharmaceutical 128
Table Selecta Biosciences Company Profile 128
Table Technology Profile of Selecta Biosciences 129
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Selecta Biosciences 2010-2015 130
Figure Nanopharmaceuticals Revenue Growth Rate 130
Figure Nanopharmaceuticals Revenue Market Share of Selecta Biosciences 2010-2015 131
Table Contact Information of Selecta Biosciences 131
Table Par Pharmaceutical Company Profile 131
Table Technology Profile of Par Pharmaceutical 132
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Par Pharmaceutical 2010-2015 133
Figure Nanopharmaceuticals Revenue Growth Rate 133
Figure Nanopharmaceuticals Revenue Market Share of Par Pharmaceutical 2010-2015 134
Table Contact Information of Par Pharmaceutical 134
Table Cerulean Pharma Company Profile 134
Table Technology Profile of Cerulean Pharma 135
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Cerulean Pharma 2010-2015 136
Figure Nanopharmaceuticals Revenue Growth Rate 136
Figure Nanopharmaceuticals Revenue Market Share of Cerulean Pharma 2010-2015 137
Table Contact Information of Cerulean Pharma 137
Table Navidea Biopharmaceuticals Company Profile 138
Table Technology Profile of Navidea Biopharmaceuticals 138
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Navidea Biopharmaceuticals 2010-2015 139
Figure Nanopharmaceuticals Revenue Growth Rate 139
Figure Nanopharmaceuticals Revenue Market Share of Navidea Biopharmaceuticals 2010-2015 140
Table Contact Information of Navidea Biopharmaceuticals 140
Table Lummy Company Profile 141
Table Technology Profile of Lummy 141
Table Nanopharmaceuticals Gross (Million USD), Revenue (Million USD) and Gross Margin of Lummy 2010-2015 142
Figure Nanopharmaceuticals Revenue Growth Rate 142
Figure Nanopharmaceuticals Revenue Market Share of Lummy 2010-2015 143
Table Contact Information of Lummy 143
Figure Marketing Channels Status of Nanopharmaceuticals 144
Figure 2014 Nanopharmaceuticals Marketing Channels Share Status 145
Table Traders or Distributors of Nanopharmaceuticals with Contact Information 145
Table Global Nanopharmaceuticals Industry Market Size (Million USD) by Region, 2010-2015 146
Figure Global Revenue (Million USD) and Growth Rate of Nanopharmaceuticals 2016-2021 147
Figure Global Revenue Growth Rate of Nanopharmaceuticals 2016-2021 147
Table Revenue Market (Million USD) Analysis of Nanopharmaceuticals by Type 2016-2021 148
Table Revenue Market Share Analysis of Nanopharmaceuticals by Type 2016-2021 148
Table Revenue Market (Million USD) Analysis of Nanopharmaceuticals by Application 2016-2021 148
Table Revenue Market Share Analysis of Nanopharmaceuticals by Application 2016-2021 149
Table China Revenue, Import, Export and Consumption of Nanopharmaceuticals 2016-2021 (Million USD) 149
Table Europe Revenue, Import, Export and Consumption of Nanopharmaceuticals 2016-2021 (Million USD) 149
Table Japan Revenue, Import, Export and Consumption of Nanopharmaceuticals 2016-2021 (Million USD) 149
Table USA Revenue, Import, Export and Consumption of Nanopharmaceuticals 2016-2021 (Million USD) 150
Table Global Revenue (Million USD) of Nanopharmaceuticals by Region 2016-2021 150
Table Manufacturing Equipment Suppliers of Nanopharmaceuticals with Contact Information 151
Table Major Suppliers of Nanopharmaceuticals with Contact Information 152
Table Key Consumers of Nanopharmaceuticals with Contact Information 153

Published By: QYResearch Group
Product Code: QYResearch Group87011


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we�ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Biotechnology market as per your needs. Get the best of Biotechnology research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: